LEARN MORE>
High priorities: sustainability & continual improvement
LEARN MORE>
Actavis Completes Forest Laboratories Acquisition
>Go!

Actavis Global Operations has more than 30 manufacturing facilities around the world. Capabilities include finished dosage form manufacturing as well as active pharmaceutical ingredient (API) development and manufacturing.

We also have biosimilars capabilities headquartered at our state-of-the-art biosimilar development center in Liverpool, U.K.